Focus on germ-layer markers : A human stem cell-based model for in vitro teratogenicity testing
Focus on germ-layer markers : A human stem cell-based model for in vitro teratogenicity testing
Date
2020
Authors
Zhang, Jitao David
Barrow, Paul
Ebeling, Martin
Clemann, Nicole
Kustermann, Stefan
Editors
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
URI (citable link)
DOI (citable link)
International patent number
Link to the license
EU project number
681002
Project
EUToxRisk21
Open Access publication
Collections
Title in another language
Publication type
Journal article
Publication status
Published
Published in
Reproductive Toxicology ; 98 (2020). - pp. 286-298. - Elsevier. - ISSN 0890-6238. - eISSN 1873-1708
Abstract
Human induced pluripotent stem cells (hiPSC) were used to develop an assay format that may deliver information on teratogenicity of drugs. A human pluripotent stem cell scorecard panel was used to monitor the expression of 96 marker genes that are indicative of the stem cell state or differentiation into the ectoderm, mesoderm and endoderm lineages. We selected a human episomal iPS cell line for the assay based on karyotype stability, initial pluripotency, differentiation capacity and overall gene expression variability. The assay is based on embryoid body formation and was developed to be simply automated. In this proof of concept study, we used eight reference compounds (valproic acid, all-trans-retinoic acid, thalidomide, methotrexate, hydroxyurea, ascorbic acid, penicillin G and ibuprofen) to test the technical performance of the assay (readout stability) in concentration-response and time-course experiments. We also found that each compound affected marker gene expression in a different way. Various forms of data analysis identified 19 out of 96 early developmental genes as potential predictive markers for teratogenicity. Machine-learning models were run to exemplify how the assay will be developed further. The preliminary results from these analyses suggest that the assay could be suitable for the pre-screening of candidate pharmaceutical compounds. The approach presented here points a way towards development of a human cell-based assay that could replace the murine EST currently used to screen for early indications of potential teratogenicity of drug candidates.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
Teratogenicity, Gene egulation, Embryoid bodies, Scorecard, Human induced pluripotent stem cells
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690
JAKLIN, Manuela, Jitao David ZHANG, Paul BARROW, Martin EBELING, Nicole CLEMANN, Marcel LEIST, Stefan KUSTERMANN, 2020. Focus on germ-layer markers : A human stem cell-based model for in vitro teratogenicity testing. In: Reproductive Toxicology. Elsevier. 98, pp. 286-298. ISSN 0890-6238. eISSN 1873-1708. Available under: doi: 10.1016/j.reprotox.2020.10.011BibTex
@article{Jaklin2020-12Focus-51826, year={2020}, doi={10.1016/j.reprotox.2020.10.011}, title={Focus on germ-layer markers : A human stem cell-based model for in vitro teratogenicity testing}, volume={98}, issn={0890-6238}, journal={Reproductive Toxicology}, pages={286--298}, author={Jaklin, Manuela and Zhang, Jitao David and Barrow, Paul and Ebeling, Martin and Clemann, Nicole and Leist, Marcel and Kustermann, Stefan} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/51826"> <dc:contributor>Kustermann, Stefan</dc:contributor> <dc:contributor>Jaklin, Manuela</dc:contributor> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:issued>2020-12</dcterms:issued> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/51826/1/Jaklin_2-a542ds2j9vk72.pdf"/> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/51826"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Clemann, Nicole</dc:creator> <dc:contributor>Leist, Marcel</dc:contributor> <dc:creator>Kustermann, Stefan</dc:creator> <dc:creator>Barrow, Paul</dc:creator> <dc:contributor>Barrow, Paul</dc:contributor> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Leist, Marcel</dc:creator> <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights> <dc:contributor>Ebeling, Martin</dc:contributor> <dcterms:title>Focus on germ-layer markers : A human stem cell-based model for in vitro teratogenicity testing</dcterms:title> <dc:creator>Jaklin, Manuela</dc:creator> <dc:contributor>Clemann, Nicole</dc:contributor> <dcterms:abstract xml:lang="eng">Human induced pluripotent stem cells (hiPSC) were used to develop an assay format that may deliver information on teratogenicity of drugs. A human pluripotent stem cell scorecard panel was used to monitor the expression of 96 marker genes that are indicative of the stem cell state or differentiation into the ectoderm, mesoderm and endoderm lineages. We selected a human episomal iPS cell line for the assay based on karyotype stability, initial pluripotency, differentiation capacity and overall gene expression variability. The assay is based on embryoid body formation and was developed to be simply automated. In this proof of concept study, we used eight reference compounds (valproic acid, all-trans-retinoic acid, thalidomide, methotrexate, hydroxyurea, ascorbic acid, penicillin G and ibuprofen) to test the technical performance of the assay (readout stability) in concentration-response and time-course experiments. We also found that each compound affected marker gene expression in a different way. Various forms of data analysis identified 19 out of 96 early developmental genes as potential predictive markers for teratogenicity. Machine-learning models were run to exemplify how the assay will be developed further. The preliminary results from these analyses suggest that the assay could be suitable for the pre-screening of candidate pharmaceutical compounds. The approach presented here points a way towards development of a human cell-based assay that could replace the murine EST currently used to screen for early indications of potential teratogenicity of drug candidates.</dcterms:abstract> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-17T13:01:38Z</dcterms:available> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-11-17T13:01:38Z</dc:date> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by-nc-nd/4.0/"/> <dc:creator>Zhang, Jitao David</dc:creator> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/51826/1/Jaklin_2-a542ds2j9vk72.pdf"/> <dc:creator>Ebeling, Martin</dc:creator> <dc:contributor>Zhang, Jitao David</dc:contributor> <dc:language>eng</dc:language> </rdf:Description> </rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Yes
Refereed
Yes